Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
Open Access
- 24 September 2015
- journal article
- forum
- Published by Springer Nature in BMC Medicine
- Vol. 13 (1) , 1-9
Abstract
Idiopathic pulmonary fibrosis (IPF), the prototype of interstitial lung diseases, has the worst prognosis and is the only interstitial lung disease for which approved pharmacological treatments are available. Despite being considered a rare disease, IPF patients pose major challenges to both physicians and healthcare systems. It is estimated that a large number of IPF patients reside in BRIC countries (Brazil, Russia, India, and China) given their overall total population of approximately 3 billion inhabitants. Nevertheless, the limited availability of chest imaging in BRIC countries is considered a chief obstacle to diagnosis, since high-resolution computed tomography of the chest is the key diagnostic test for IPF. Further, obtaining reliable lung function tests and providing treatment access is difficult in the more rural areas of these countries. However, IPF might represent an opportunity for BRIC countries: the exponentially increasing demand for the enrollment of IPF patients in clinical trials of new drugs is predicted to face a shortage of patients – BRIC countries may thus play a crucial role in advancing towards a cure for IPF.Keywords
This publication has 33 references indexed in Scilit:
- Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological dataBMC Pulmonary Medicine, 2013
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary FibrosisNew England Journal of Medicine, 2012
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2011
- Prognostic Factors in Lung Transplantation: The Santa Casa de Porto Alegre ExperienceTransplantation, 2011
- Prevalência da doença do refluxo gastroesofágico em pacientes com fibrose pulmonar idiopáticaJornal Brasileiro de Pneumologia, 2009
- Subacute and chronic hypersensitivity pneumonitis: Histopathological patterns and survivalRespiratory Medicine, 2009
- Influence of Feixian Formula on serum transforming growth factor-β1 and platelet-derived growth factor in rats with bleomycin-induced pulmonary fibrosisJournal of Chinese Integrative Medicine, 2008
- Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKThorax, 2006
- Survival in idiopathic pulmonary fibrosis—cytotoxic agents compared to corticosteroidsRespiratory Medicine, 2006
- Mortality caused by idiopathic pulmonary fibrosis in the State of Rio Grande do Sul (Brazil)Jornal de Pneumologia, 2003